Newron Pharmaceuticals
NWRN.SW
#8149
Rank
$0.31 B
Marketcap
$15.13
Share price
1.50%
Change (1 day)
73.71%
Change (1 year)

Half-year Reports

Thumbnail Newron Pharmaceuticals Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2024-h1

Half-year Report 2024-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2020-h1

Half-year Report 2020-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2019-h1

Half-year Report 2019-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2018-h1

Half-year Report 2018-h1

Language: English

View Half-year Report
Thumbnail Newron Pharmaceuticals Half-year Report 2017-h1

Half-year Report 2017-h1

Language: English

View Half-year Report